Skip to main content
Clinical Trials/NCT03032900
NCT03032900
Terminated
N/A

Right Ventricular Dysfunction Incidence After Major Lung Resection, a Prospective Study.

University Hospital, Montpellier1 site in 1 country110 target enrollmentJanuary 1, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Major Lung Resection
Sponsor
University Hospital, Montpellier
Enrollment
110
Locations
1
Primary Endpoint
Right ventricular dysfunction
Status
Terminated
Last Updated
7 years ago

Overview

Brief Summary

This study aims to describe incidence of right ventricular dysfunction after major lung resection with echocardiography criteria.

Detailed Description

Few clinical trial studied the incidence of right ventricular dysfunction after major lung resection and time frame of occurrence. In this prospective observational study the right ventricular function will be mesure with echocardiographic criteria. Echocardiographic exam will be standardised and be realised day before surgery (at the same time that inclusion), day 1, day 2 and day 3 after surgery. In order to assess prognostic value of right dysfunction after lung resection, data as hospitalization stay, complications and survival will be collected at 6 months. Cardiac cycles will be recorded and be analysed by a single observer blind to the clinical finding and other echocardiographic measurements.

Registry
clinicaltrials.gov
Start Date
January 1, 2017
End Date
July 2, 2018
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Written consent
  • Patient older than 18 years
  • Major lung surgery (pneumonectomy, lobectomy)

Exclusion Criteria

  • Pre-existing pulmonary arteria hypertension
  • Post-operative surgical complication on day 1 to 3 (bleeding, revision surgery)
  • Technical difficulty preventing adequate echocardiographic assessment
  • Patient refusal

Outcomes

Primary Outcomes

Right ventricular dysfunction

Time Frame: 5 days

Without pre-existing pulmonary arteria hypertension, it will be assess with echocardiography criteria : PAPS \> 35mmHg or right ventricular dilatation or right systolic markers abnormalities.

Secondary Outcomes

  • Risk factors(5 days)
  • Time frame to right ventricular dysfunction(5 days)
  • Assessment of 2D strain for right ventricular dysfunctio(5 days)
  • Estimate impact of right ventricular dysfunction on patient prognosis.(5 days)

Study Sites (1)

Loading locations...

Similar Trials